Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

By sjmartinez • April 11, 2023

Pavord ID, Deniz Y, Corren J, Casale TB, FitzGerald JM, Izuhara K, Daizadeh N, Ortiz B, Johnson RR, Harel S, Djandji M, Goga L, Crikelair N, Rowe PJ, Busse WW. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma. J Allergy Clin Immunol Pract. 2023 Apr;11(4):1213-1220.e2. doi: 10.1016/j.jaip.2022.11.043. Epub 2022 Dec 16. PMID: 36535524.

Tags: Allergy & Immunology, asthma, Dupilumab, FEV(1), Fractional exhaled nitric oxide, Predictive biomarker, Publications, Severe exacerbations

From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma

Brown K, Anderson L. From Mild to Mayhem: A Life-Threatening Exacerbation of Mild Asthma. Cureus. 2024 Sep 30;16(9):e70558. doi: 10.7759/cureus.70558. PMID: 39479137; PMCID: PMC11524714.

Psychosocial issues and quality of life associated with food allergy

Kachru R. Psychosocial issues and quality of life associated with food allergy. J Food Allergy. 2024 Jul 8;2(1):95-98. doi: 10.2500/jfa.2020.2.200025. PMID: 39022158; PMCID: PMC11250222.

Dupilumab Reduces Exacerbations Independent of Changes in Biomarkers in Moderate-to-Severe Asthma

Pavord ID, Casale TB, Corren J, FitzGerald MJ, Deniz Y, Altincatal A, Gall R, Pandit-Abid N, Radwan A, Jacob-Nara JA, Rowe PJ, Busse WW. Dupilumab[...]